Method for increasing the bioavailability of inhaled compounds - US 2019/016177 A1
(2019)
Files
US2019160177A11.pdf
Open Access - Adobe PDF
- 2.88 MB
Details
- Authors
Van Snick, Jacques 
- Abstract
- The present invention relates to a compound comprising one or more PEG moieties , wherein said compound is a therapeutic agent active for treating a respiratory disease . The present invention also relates to a method for preventing and / or treating a respiratory disease in a subject in need thereof comprising the administration of a PEGylated therapeutic agent. Another object of the invention is a method for enhancing the bioavailability of a therapeutic agent , for enhancing the pulmonary residency of a therapeutic agent and / or for reducing the pulmonary clearance of a therapeutic agent , wherein said methods comprise the PEGylation of the therapeutic agent .
- Affiliations
Citations
Vanbever, R., Koussoroplis, S., Cataldo, D., & Van Snick, J. (2019). Method for increasing the bioavailability of inhaled compounds - US 2019/016177 A1. https://hdl.handle.net/2078.5/240581